About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Tennessee | 18,955 Studies Near You

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 18,955 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2101-2120 of 18,955 trials

RecruitingBone Mineral Density Agreement Study Between EOSedge™ Versus Traditional DXAThe purpose of this research is to collect medical imaging data to allow for the comparison of bone mineral density measurements from two different types of low-dose x-ray exams…NCT06659055·Phoenix, Arizona and 3 others CompletedGemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy, such as gemcitabine and vinorelbine, use different ways to stop cancer cells from dividing so they stop growing or die.NCT00070304·Birmingham, Alabama and 122 others

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

CompletedLong Term Safety of NaldemedineThe purpose of this study is to evaluate the long-term safety of naldemedine for the treatment of constipation due to opioid therapy.NCT01965652·Birmingham, Alabama and 185 others

CompletedA Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.The primary objective is to compare the efficacy between three doses of AZD0865 (25, 50 and 75 mg).NCT00206284·Alabaster, Alabama and 201 others

TerminatedElectrode Placement and Audiologic Outcomes With the Advanced Bionics HiFocus L23 ElectrodeThe goal of this study is to measure patient performance after cochlear implantation with the Food and Drug Administration (FDA) approved Advanced Bionics HiFocus L23 device.NCT03858647·Nashville, Tennessee

TerminatedA Trial of Bardoxolone Methyl in Patients With ADPKD - FALCONThis international, multi-center, randomized, double-blind, placebo-controlled Phase 3 trial will study the safety, tolerability, and efficacy of bardoxolone methyl in qualified…NCT03918447·Birmingham, Alabama and 136 others

CompletedA Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.The purpose of this study is to investigate the safety and determine the maximum tolerated dose of TAS-102 administered in combination with CPT-11 in patients with advanced…NCT01916447·Los Angeles, California and 3 others

RecruitingStudy of CM4620 to Reduce the Severity of Pancreatitis Due to AsparaginaseThis is a phase I/II clinical trial assessing the tolerability and efficacy of CM4620 in children and young adults with acute pancreatitis caused by asparaginase.NCT04195347·Charlotte, North Carolina and 2 others

CompletedIV Lacosamide: The Safety of Intravenous LacosamideThe purpose of this study is to evaluate the safety of IV Lacosamide in children ages 4-35.NCT01981447·Memphis, Tennessee

TerminatedCONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")The objectives of this study are to collect post-market confirmatory evidence of the safety and effectiveness of the Bard® LifeStent® Vascular Stent System and LifeStent® XL…NCT00908947·Los Angeles, California and 28 others

CompletedEfficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine PreventionThis study will evaluate the safety and tolerability of the following doses of atogepant (AGN-241689): 10 mg once daily (QD), 30 mg QD, 30 mg twice daily (BID), 60 mg QD, and 60…NCT02848326·Birmingham, Alabama and 74 others

CompletedClinical Performance Comparison of Two Contact LensesThe purpose of this study is to compare the clinical performance of two contact lenses.NCT00975585·North Little Rock, Arkansas and 24 others

CompletedImpact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens WearersTo compare the efficacy of XDEMVY ophthalmic drop to its vehicle control for the treatment of Demodex blepharitis and its impact on the soft contact lens wearing experience.NCT06182358·Cave Creek, Arizona and 13 others

RecruitingTesting the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer…NCT04267848·Anchorage, Alaska and 1150 others

TerminatedStudy to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)Rheumatoid Arthritis (RA) is an inflammatory disease of the joints causing pain, stiffness, swelling and loss of joint function.NCT04888585·Phoenix, Arizona and 219 others

CompletedStudy to Evaluate Safety and Tolerability of Iberdomide (CC-220) in Participants With Kidney Impairment Compared to Participants With Normal Kidney FunctionThis is an open-label study of iberdomide in participants with severe renal impairment or participants receiving dialysis compared to participants with normal renal function.NCT04933747·Orlando, Florida and 2 others

Active not recruitingDoxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin LymphomaThis phase II trial evaluates how well AVD (doxorubicin, vinblastine, dacarbazine) in combination with brentuximab vedotin and nivolumab work in treating patients with stage I-II…NCT03233347·Duarte, California and 8 others

CompletedResearch & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab TestEvaluation of the agreement between fingerstick samples, venous blood, serum and plasma samples when using the LumiraDx SARS-CoV-2 Ab Test against the reference method, using…NCT04597047·Tucson, Arizona and 3 others

CompletedA Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult VolunteersTo evaluate the safety and immunogenicity of ALVAC-HIV MN120TMG (vCP205) in comparison to ALVAC-RG rabies glycoprotein (vCP65) as a control when administered in HIV-1 negative…NCT00001055·Birmingham, Alabama and 5 others

CompletedStudy to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland DysfunctionTo evaluate the efficacy and safety of two strengths of HY02 Ointment versus Vehicle administered twice daily for twelve weeks in subjects with a diagnosis of Inflamed Meibomian…NCT03888378·Azusa, California and 19 others

PreviousPage 106 of 948Next

Diabetes

in Tennessee

Heart Diseasein Tennessee